Ovarian Neoplasms: all 2,757 studies

Page 28 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.

• Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial CancerCompletedNCT00004876Phase 2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerTerminatedNCT00004221Phase 2
• Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian CancerStatus unknownNCT00004206Phase 2
• Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial CancerCompletedNCT00004177Phase 1/2
• Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving ChemotherapyCompletedNCT00004166Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and ChemotherapyStatus unknownNCT00004115Phase 3
• Liposomal Cisplatin in Treating Patients With Recurrent Ovarian CancerCompletedNCT00004083Phase 2
• Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerStatus unknownNCT00004064Phase 2
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerTerminatedNCT00004037Phase 2
• Bryostatin 1 in Treating Patients With Ovarian Epithelial CancerCompletedNCT00004008Phase 2
• Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial CancerCompletedNCT00003998Phase 3
• ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian CancerCompletedNCT00003892Phase 2
• Toremifene in Treating Patients With Ovarian CancerWithdrawnNCT00003865Phase 2
• Quality-of-Life Study of Patients With Previously Treated Ovarian CancerTerminatedNCT00003794
• IM-862 in Treating Patients With Recurrent Ovarian CancerCompletedNCT00003773Phase 1
• Quality-of-Life Assessment in Patients With Ovarian CancerCompletedNCT00003772
• Radiolabeled Folic Acid and Imaging to Detect Ovarian CancerCompletedNCT00003763Not applicable
• Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian CancerStatus unknownNCT00003733Phase 2
• Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian CancerCompletedNCT00003732Phase 2
• Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian CancerCompletedNCT00003695Phase 3
• Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00003670Phase 2
• Gene Therapy in Treating Patients With Ovarian CancerCompletedNCT00003588Phase 1
• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian CancerTerminatedNCT00003532Phase 2
• Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the PeritoneumCompletedNCT00003523Phase 2
• Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00003450Phase 1
• Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian CancerCompletedNCT00003449Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial CancerCompletedNCT00003413Phase 2
• Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube CancerTerminatedNCT00003382Phase 1
• Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNCT00003345Phase 2
• Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian CancerCompletedNCT00003322Phase 3
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian CancerCompletedNCT00003297Phase 1/2
• Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian CancerCompletedNCT00003214Phase 3
• Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and PlatinumStatus unknownNCT00003160Phase 2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00003136Phase 1/2
• S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in RemissionCompletedNCT00003120Phase 3
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian CancerCompletedNCT00003080Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerCompletedNCT00003072Phase 2
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal CancerStatus unknownNCT00003064Phase 1/2
• Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete RemissionCompletedNCT00002977Phase 1
• Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian CancerCompletedNCT00002928Phase 2
• Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00002895Phase 3
• Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian CancerCompletedNCT00002894Phase 3
• Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial CancerTerminatedNCT00002819Phase 3
• Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian CancerCompletedNCT00002734Phase 1
• Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00002717Phase 3
• Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian CancerCompletedNCT00002671Phase 2
• Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian CancerStatus unknownNCT00002487Phase 2
• Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial CancerStatus unknownNCT00002477Phase 3
• Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian CancerCompletedNCT00002474Phase 2
• A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)CompletedNCT00001938
• Microarray Analysis for Human Genetic DiseaseCompletedNCT00001898
• p53 Vaccine for Ovarian CancerTerminatedNCT00001827Phase 2
• Methods in Education for Breast Cancer GeneticsCompletedNCT00001806Phase 3
• Outcomes of Education and Counseling for BRCA1 TestingCompletedNCT00001468
• A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and CisplatinCompletedNCT00001427Phase 2
• A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian CancerCompletedNCT00001426Phase 2
• A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer PatientsCompletedNCT00001272Phase 1

← Ovarian Neoplasms overview